ArticleNigerian medical journal : journal of the Nigeria Medical Association
Investigating serum levels of IL-6 and TNF alpha, and the risk of thrombosis in newly diagnosed chemotherapy naïve obese cancer patients.
Article in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obesity and cancer increase thrombosis risk. IL-6 and TNF-α, are key inflammatory cytokines, which may contribute to hypercoagulability in newly diagnosed, chemotherapy-naïve obese cancer patients, warranting further investigation. This study aimed to investigate the serum levels of these inflammatory biomarkers and risk of VTE in chemotherapy naïve obese cancer patients (CNOCPs). Methodology: The study was cross-sectional analytical in design. The participants consisted of newly diagnosed patients with solid malignancies recruited from adult oncology clinics of a Nigerian tertiary hospital. They were grouped into two: case group (n = 37) consisting of chemotherapy naïve OCPs and control group (n = 63) consisting of chemotherapy naïve non-OCPs Patients were risk assessed using the Khorana scoring system. All the patients' serum samples were assayed by ELISA technique for IL-6 and TNF-α. History of VTE was obtained from the patients' case notes and by direct interviews with the patients. Results: The mean age of the participants was 48.44±13.4 (range = 20 - 76) years, and the mean BMI was 26.80±6.3Kg/m Conclusion: The inflammatory biomarkers were significantly higher in chemotherapy naïve OCPs than the non-obese controls. Additionally, they are at higher risk of VTE. These findings could strengthen clinicians' disposition for prompt initiation of thromboprophylaxis in OCPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.